These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 10602332

  • 41. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K, Halushka PV, Yan YT, Wong PY.
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
    [Abstract] [Full Text] [Related]

  • 42. Contraction kinetics of isolated human myometrium during menstrual cycle and pregnancy.
    Tchirikov M, Peiper U, Schröder HJ.
    BJOG; 2000 Jan; 107(1):62-7. PubMed ID: 10645863
    [Abstract] [Full Text] [Related]

  • 43. Losartan prevents thromboxane A2/prostanoid (TP) receptor mediated increase in microvascular permeability in the rat.
    Valentin JP, Jover B, Maffre M, Bertolino F, Bessac AM, John GW.
    Am J Hypertens; 1997 Sep; 10(9 Pt 1):1058-63. PubMed ID: 9324114
    [Abstract] [Full Text] [Related]

  • 44. Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.
    Säfholm J, Manson ML, Bood J, Delin I, Orre AC, Bergman P, Al-Ameri M, Dahlén SE, Adner M.
    J Allergy Clin Immunol; 2015 Nov; 136(5):1232-9.e1. PubMed ID: 25962903
    [Abstract] [Full Text] [Related]

  • 45. Gestational resistance to the pulmonary vasoconstrictor effect of the TxA2 mimetic U-46619: possible mechanism.
    Losonczy G, Brown G, Mucha I, Klocke R, Muller V, Merkely B, Tornoci L, Rosivall L, Venuto R.
    Am J Physiol; 1997 Jun; 272(6 Pt 2):R1734-9. PubMed ID: 9227584
    [Abstract] [Full Text] [Related]

  • 46. The influence of smooth muscle content and orientation in dissected human pregnant myometrial strips on contractility measurements.
    Crankshaw DJ, Sweeney EM, O'Brien YM, Walsh JM, Dockery P, Morrison JJ.
    Eur J Pharmacol; 2014 Sep 05; 738():245-9. PubMed ID: 24886879
    [Abstract] [Full Text] [Related]

  • 47. Evidence for partial agonist properties of daltroban (BM 13,505) at TP receptors in the anaesthetized open-chest rat.
    Bertolino F, Valentin JP, Patoiseau JF, Rieu JP, Colpaert FC, John GW.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct 05; 356(4):462-6. PubMed ID: 9349632
    [Abstract] [Full Text] [Related]

  • 48. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle.
    Dorn GW, Becker MW, Davis MG.
    J Biol Chem; 1992 Dec 05; 267(34):24897-905. PubMed ID: 1447225
    [Abstract] [Full Text] [Related]

  • 49. In vitro characterization of prostanoid receptors on human myometrium at term pregnancy.
    Senior J, Marshall K, Sangha R, Clayton JK.
    Br J Pharmacol; 1993 Feb 05; 108(2):501-6. PubMed ID: 8448599
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Characterization of prostanoid receptors present on adrenergic neurons innervating the porcine uterine longitudinal muscle.
    Cao J, Nakamura T, Kitazawa T, Yamashiki N, Yamamoto T, Taneike T.
    Prostaglandins Other Lipid Mediat; 2008 Jun 05; 86(1-4):26-34. PubMed ID: 18403225
    [Abstract] [Full Text] [Related]

  • 52. Cloning and pharmacologic characterization of a thromboxane A2 receptor from K562 (human chronic myelogenous leukemia) cells.
    D'Angelo DD, Davis MG, Ali S, Dorn GW.
    J Pharmacol Exp Ther; 1994 Nov 05; 271(2):1034-41. PubMed ID: 7965765
    [Abstract] [Full Text] [Related]

  • 53. Pharmacological characterization of prostanoid receptors mediating vasoconstriction in human umbilical vein.
    Daray FM, Minvielle AI, Puppo S, Rothlin RP.
    Br J Pharmacol; 2003 Aug 05; 139(8):1409-16. PubMed ID: 12922927
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Involvement of the TP receptor in TNF-α-induced endothelial tissue factor expression.
    Del Turco S, Basta G, Lazzerini G, Chancharme L, Lerond L, De Caterina R.
    Vascul Pharmacol; 2014 Aug 05; 62(2):49-56. PubMed ID: 24699252
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. TRA-418, a novel compound having both thromboxane A(2) receptor antagonistic and prostaglandin I(2) receptor agonistic activities: its antiplatelet effects in human and animal platelets.
    Yamada N, Miyamoto M, Isogaya M, Suzuki M, Ikezawa S, Ohno M, Otake A, Umemura K.
    J Thromb Haemost; 2003 Aug 05; 1(8):1813-9. PubMed ID: 12911598
    [Abstract] [Full Text] [Related]

  • 58. The bovine thromboxane A2 receptor: molecular cloning, expression, and functional characterization.
    Muck S, Weber AA, Meyer-Kirchrath J, Schrör K.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan 05; 357(1):10-6. PubMed ID: 9459567
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.